In another case, dexamethasone (DXM)‐loaded IFN‐γ‐treated major histocompatibility complex‐deficient cancer membrane‐cloaked nanoparticles (IM‐MNPs/DXM) were fabricated to exploit the immunosuppressive ability of tumor cells for the treatment of systemic lupus erythematosus (SLE).[104]. Here, IFNG is linked to systemic lupus erythematosus.